CLINICAL TRIALS PROFILE FOR ERYTHROMYCIN LACTOBIONATE
✉ Email this page to a colleague
All Clinical Trials for erythromycin lactobionate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00034736 ↗ | A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 2002-08-01 | The purpose of this study is to determine the safety and efficacy of levofloxacin in the treatment of children with community acquired pneumonia. |
NCT02605122 ↗ | Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia | Terminated | Biomedical Advanced Research and Development Authority | Phase 2/Phase 3 | 2016-04-01 | This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the safety and efficacy of solithromycin in children and adolescents with community-acquired bacterial pneumonia (CABP). |
NCT02605122 ↗ | Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia | Terminated | Cempra Inc | Phase 2/Phase 3 | 2016-04-01 | This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the safety and efficacy of solithromycin in children and adolescents with community-acquired bacterial pneumonia (CABP). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for erythromycin lactobionate
Condition Name
Clinical Trial Locations for erythromycin lactobionate
Trials by Country
Clinical Trial Progress for erythromycin lactobionate
Clinical Trial Phase
Clinical Trial Sponsors for erythromycin lactobionate
Sponsor Name